DNB ASSET MANAGEMENT AS – Neurocrine Biosciences, Inc. Transaction History
DNB ASSET MANAGEMENT AS portfolio value:
$9.32M
portfolio value
DNB ASSET MANAGEMENT AS quarter portfolio value change:
+8.96%
quarter
Neurocrine Biosciences, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Decrease | -30.52% | -38.55K shares | -2.99M | $106.21 | 87.76K |
| Q2 2022 | share | Decrease | -6.53% | -8.82K shares | -356.52K | $97.48 | 126.32K |
| Q1 2022 | share | Decrease | -3.89% | -5.46K shares | 693.82K | $93.75 | 135.15K |
| Q4 2021 | share | Increase | +18.89% | 22.34K shares | 632.72K | $84.63 | 140.62K |
| Q3 2021 | share | Decrease | -14.43% | -19.94K shares | -2.10M | $95.91 | 118.27K |
| Q2 2021 | share | Increase | +16.38% | 19.45K shares | 1.90M | $97.32 | 138.22K |
| Q1 2021 | share | Increase | +237.34% | 83.56K shares | 8.17M | $97.25 | 118.76K |
| Q4 2020 | share | Increase | +184.48% | 22.83K shares | 2.18M | $95.85 | 35.20K |
| Q3 2020 | share | 0.00% | 0 shares | -319.79K | $96.16 | 12.37K | |
| Q2 2020 | share | Increase | +13.55% | 1.47K shares | 566.56K | $122 | 12.37K |
| Q1 2020 | share | Decrease | -7.86% | -930 shares | -328.19K | $86.55 | 10.89K |
| Q4 2019 | share | Increase | 0.00% | 11.82K shares | 1.27M | $107.49 | 11.82K |